Fabienne Thomas

Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors

Birgit Geoerger, Darren Hargrave, Fabienne Thomas et al. · Neuro-Oncology · 2010 · 155 citations · Full text

Pharmacokinetics and efficacy of a long-acting formulation of the new somatostatin analog BIM 23014 in patients with acromegaly.

I Héron, Fabienne Thomas, M Déro et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 118 citations

Pituitary Gland, Growth Hormone, Human Growth +9

<i><scp>UGT</scp>1A1</i> genotype and irinotecan therapy: general review and implementation in routine practice

Marie-Christine Étienne-Grimaldi, Jean‐Christophe Boyer, Fabienne Thomas et al. · Fundamental and Clinical Pharmacology · 2015 · 108 citations

Pathology, Pharmacotherapy, Advanced Colorectal Cancer +20

New advances in DPYD genotype and risk of severe toxicity under capecitabine

Marie-Christine Étienne-Grimaldi, Jean-Christophe Boyer, Christophe Béroud et al. · PLoS ONE · 2017 · 102 citations · Full text

Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide.

Isabelle Morange, F de Boisvilliers, Philippe Chanson et al. · The Journal of Clinical Endocrinology & Metabolism · 1994 · 101 citations

Acromegalic Patients, Clinical Therapeutic, Pharmacology +7